Laura Valtere

Laura Valtere is a Research Fellow affiliated with the University of Copenhagen’s Centre for Advanced Studies in Bioscience Innovation Law (CeBIL). She holds a Dr. iur. from the Max-Plank-Institute for Innovation and Competition/Ludwig Maximilian University (2024), an LL.M. in European and International Business Law (2018), and a Mag.Iur. in Law (2014) from the University of Latvia. Her professional journey includes roles such as Postdoctoral Fellow (CeBIL), Research Fellow (Ludwig-Maximilians-Universität München, 2022–2023), R&D Specialist at the University of Luxembourg (2022–2024), and legal consultancy with Latvia’s Ministry of Justice (2012–2013).

Her research focuses on IP law and biosolutions, with emphasis on genomic techniques, novel foods, sustainable healthcare innovation, antimicrobial resistance, and advanced therapy medicinal products. She explores regulatory frameworks for biobased innovations, AI applications in healthcare and agriculture, and non-patent-based incentives for innovation. Her work intersects pharmaceutical regulation, patent law, and comparative legal systems.

Key publications include a forthcoming Springer monograph on personalized medicine and IP regulation, GRUR Int articles analyzing patent and regulatory exclusivity dynamics, and EU Commission studies on supplementary protection certificates. Her work highlights trends in balancing IP rights with public health needs and harmonizing cross-jurisdictional regulations.

While no scientific awards are listed, her contributions to EU policy research and comparative IP analysis demonstrate significant scholarly impact. Her advisory roles include contributions to regulatory frameworks in the EU and non-EU jurisdictions. She is affiliated with CeBIL, a multidisciplinary hub for bioscience innovation law.